{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:41:15Z","timestamp":1790617275602,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","geriatric.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Geriatric Medicine"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.cger.2020.01.001","type":"journal-article","created":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T20:40:22Z","timestamp":1579725622000},"page":"365-377","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":109,"title":["Cognitive Impairment and Dementia in Parkinson Disease"],"prefix":"10.1016","volume":"36","author":[{"given":"Jennifer G.","family":"Goldman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Sieg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cger.2020.01.001_bib1","first-page":"47","article-title":"Cognitive decline and quality of life in incident Parkinson's disease: the role of attention","volume":"27","author":"Lawson","year":"2016","journal-title":"ParkinsonismRelatDisord"},{"issue":"4","key":"10.1016\/j.cger.2020.01.001_bib2","first-page":"208","article-title":"Cognitive impairment in Parkinson disease: impact on quality of life, disability, and caregiver burden","volume":"25","author":"Leroi","year":"2012","journal-title":"J\u00a0GeriatrPsychiatryNeurol"},{"issue":"2","key":"10.1016\/j.cger.2020.01.001_bib3","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/psyg.12196","article-title":"Observational study of quality of life of Parkinson's patients and their caregivers","volume":"17","author":"Corallo","year":"2017","journal-title":"Psychogeriatrics"},{"key":"10.1016\/j.cger.2020.01.001_bib4","first-page":"608","article-title":"The spectrum of cognitive impairment in Lewy body diseases","volume":"29","author":"Goldman","year":"2014","journal-title":"MovDisord"},{"issue":"4","key":"10.1016\/j.cger.2020.01.001_bib5","first-page":"287","article-title":"Subjective cognitive complaints in Parkinson disease without dementia: a preliminary study","volume":"22","author":"Koster","year":"2015","journal-title":"ApplNeuropsycholAdult"},{"issue":"3","key":"10.1016\/j.cger.2020.01.001_bib6","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/ene.12219","article-title":"Subthreshold depression and subjective cognitive complaints in Parkinson's disease","volume":"21","author":"Santangelo","year":"2014","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.cger.2020.01.001_bib7","first-page":"79","article-title":"Cognitive complaints in Parkinson's disease: its relationship with objective cognitive decline","volume":"257","author":"Dujardin","year":"2010","journal-title":"J\u00a0Neurol"},{"issue":"4","key":"10.1016\/j.cger.2020.01.001_bib8","first-page":"276","article-title":"Do subjective memory complaints herald the onset of mild cognitive impairment in Parkinson disease?","volume":"27","author":"Erro","year":"2014","journal-title":"J\u00a0GeriatrPsychiatryNeurol"},{"issue":"1","key":"10.1016\/j.cger.2020.01.001_bib9","first-page":"16","article-title":"Subjective cognitive complaints and objective cognitive impairment in Parkinson's disease","volume":"14","author":"Hong","year":"2018","journal-title":"J\u00a0ClinNeurol"},{"issue":"4","key":"10.1016\/j.cger.2020.01.001_bib10","first-page":"394","article-title":"Cognitive profiling of Parkinson disease patients with mild cognitive impairment and dementia","volume":"20","author":"Biundo","year":"2014","journal-title":"ParkinsonismRelatDisord"},{"issue":"13","key":"10.1016\/j.cger.2020.01.001_bib11","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1212\/01.wnl.0000338632.00552.cb","article-title":"Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study","volume":"72","author":"Aarsland","year":"2009","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.cger.2020.01.001_bib12","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1212\/WNL.0b013e3181f39d0e","article-title":"Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis","volume":"75","author":"Aarsland","year":"2010","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.cger.2020.01.001_bib13","first-page":"919","article-title":"Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease","volume":"30","author":"Weintraub","year":"2015","journal-title":"MovDisord"},{"issue":"4","key":"10.1016\/j.cger.2020.01.001_bib14","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1212\/WNL.0000000000000066","article-title":"Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study","volume":"82","author":"Yarnall","year":"2014","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.cger.2020.01.001_bib15","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1212\/WNL.0b013e31829c5c86","article-title":"Evolution of mild cognitive impairment in Parkinson disease","volume":"81","author":"Broeders","year":"2013","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.cger.2020.01.001_bib16","first-page":"1814","article-title":"MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI","volume":"26","author":"Litvan","year":"2011","journal-title":"MovDisord"},{"issue":"12","key":"10.1016\/j.cger.2020.01.001_bib17","first-page":"1689","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson's disease","volume":"22","author":"Emre","year":"2007","journal-title":"MovDisord"},{"key":"10.1016\/j.cger.2020.01.001_bib18","first-page":"26","article-title":"Dementia in Parkinson's disease","volume":"374","author":"Hanagasi","year":"2017","journal-title":"J\u00a0NeurolSci"},{"key":"10.1016\/j.cger.2020.01.001_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41531-018-0055-3","article-title":"Cognitive Impairment in Parkinson's disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health","volume":"4","author":"Goldman","year":"2018","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.cger.2020.01.001_bib20","first-page":"837","article-title":"The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years","volume":"23","author":"Hely","year":"2008","journal-title":"MovDisord"},{"key":"10.1016\/j.cger.2020.01.001_bib21","first-page":"16018","article-title":"Cognitive decline in Parkinson's disease: the complex picture","volume":"2","author":"Biundo","year":"2016","journal-title":"NPJParkinsons Dis"},{"issue":"4","key":"10.1016\/j.cger.2020.01.001_bib22","first-page":"511","article-title":"Initial cognitive changes in Parkinson's disease","volume":"33","author":"Weintraub","year":"2018","journal-title":"MovDisord"},{"issue":"7","key":"10.1016\/j.cger.2020.01.001_bib23","first-page":"1056","article-title":"Mild cognitive impairment as a risk factor for Parkinson's disease dementia","volume":"32","author":"Hoogland","year":"2017","journal-title":"MovDisord"},{"issue":"3","key":"10.1016\/j.cger.2020.01.001_bib24","first-page":"349","article-title":"Diagnostic criteria for mild cognitive impairment in Parkinson's disease: movement disorder society task force guidelines","volume":"27","author":"Litvan","year":"2012","journal-title":"MovDisord"},{"issue":"2","key":"10.1016\/j.cger.2020.01.001_bib25","first-page":"131","article-title":"Parkinson's disease mild cognitive impairment: application and validation of the criteria","volume":"4","author":"Geurtsen","year":"2014","journal-title":"J\u00a0Parkinsons Dis"},{"issue":"5","key":"10.1016\/j.cger.2020.01.001_bib26","first-page":"584","article-title":"The tools of the trade: a state of the art \"How to Assess Cognition\" in the patient with Parkinson's disease","volume":"29","author":"Marras","year":"2014","journal-title":"MovDisord"},{"issue":"2","key":"10.1016\/j.cger.2020.01.001_bib27","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/mds.27233","article-title":"Global scales for cognitive screening in Parkinson's disease: critique and recommendations","volume":"33","author":"Skorvanek","year":"2018","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.cger.2020.01.001_bib28","first-page":"430","article-title":"Risk of Parkinson's disease dementia related to level 1 MDS PD-MCI","volume":"34","author":"Hoogland","year":"2019","journal-title":"MovDisord"},{"issue":"10","key":"10.1016\/j.cger.2020.01.001_bib29","first-page":"1048","article-title":"Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort","volume":"30","author":"Hobson","year":"2015","journal-title":"Int J GeriatrPsychiatry"},{"key":"10.1016\/j.cger.2020.01.001_bib30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000341998","article-title":"Cognitive impairment in Parkinson's disease: the dual syndrome hypothesis","volume":"29","author":"Kehagia","year":"2013","journal-title":"Neurodegener Dis"},{"issue":"11","key":"10.1016\/j.cger.2020.01.001_bib31","first-page":"1623","article-title":"Abolishing the 1-year rule: how much evidence will be enough?","volume":"31","author":"Postuma","year":"2016","journal-title":"MovDisord"},{"key":"10.1016\/j.cger.2020.01.001_bib32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fneur.2018.00123","article-title":"Parkinson's disease dementia and dementia with lewy bodies have similar neuropsychological profiles","volume":"9","author":"Aldridge","year":"2018","journal-title":"Front Neurol"},{"issue":"1","key":"10.1016\/j.cger.2020.01.001_bib33","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.cger.2020.01.001_bib34","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1001\/archneurol.2012.1608","article-title":"Pathologic accumulation of alpha-synuclein and Abeta in Parkinson disease patients with dementia","volume":"69","author":"Kotzbauer","year":"2012","journal-title":"Arch Neurol"},{"issue":"11","key":"10.1016\/j.cger.2020.01.001_bib35","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1212\/WNL.0b013e3182698d4a","article-title":"Abeta-amyloid deposition in patients with Parkinson disease at risk for development of dementia","volume":"79","author":"Petrou","year":"2012","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.cger.2020.01.001_bib36","first-page":"928","article-title":"Amyloid deposition in Parkinson's disease and cognitive impairment: a systematic review","volume":"30","author":"Petrou","year":"2015","journal-title":"MovDisord"},{"issue":"5","key":"10.1016\/j.cger.2020.01.001_bib37","first-page":"634","article-title":"The neurobiological basis of cognitive impairment in Parkinson's disease","volume":"29","author":"Halliday","year":"2014","journal-title":"MovDisord"},{"issue":"4","key":"10.1016\/j.cger.2020.01.001_bib38","doi-asserted-by":"crossref","first-page":"561-e20","DOI":"10.1111\/ene.13258","article-title":"Genetic risk factors for cognitive decline in Parkinson's disease: a review of the literature","volume":"24","author":"Fagan","year":"2017","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.cger.2020.01.001_bib39","first-page":"95","article-title":"GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease","volume":"31","author":"Mata","year":"2016","journal-title":"MovDisord"},{"issue":"4","key":"10.1016\/j.cger.2020.01.001_bib40","first-page":"342","article-title":"Perceived and performance-based executive dysfunction in Parkinson's disease","volume":"36","author":"Lanni","year":"2014","journal-title":"J\u00a0ClinExpNeuropsychol"},{"issue":"9","key":"10.1016\/j.cger.2020.01.001_bib41","first-page":"812","article-title":"Measuring functional impact of cognitive impairment: validation of the Parkinson's disease cognitive functional rating scale","volume":"19","author":"Kulisevsky","year":"2013","journal-title":"ParkinsonismRelatDisord"},{"key":"10.1016\/j.cger.2020.01.001_bib42","first-page":"21","article-title":"The Penn Parkinson's daily activities questionnaire-15: psychometric properties of a brief assessment of cognitive instrumental activities of daily living in Parkinson's disease","volume":"25","author":"Brennan","year":"2016","journal-title":"ParkinsonismRelatDisord"},{"issue":"5","key":"10.1016\/j.cger.2020.01.001_bib43","first-page":"261","article-title":"Modified pfeffer questionnaire for functional assessment in Parkinson disease","volume":"30","author":"Almeida","year":"2017","journal-title":"J\u00a0GeriatrPsychiatryNeurol"},{"issue":"16","key":"10.1016\/j.cger.2020.01.001_bib44","first-page":"2314","article-title":"Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force","volume":"22","author":"Dubois","year":"2007","journal-title":"MovDisord"},{"issue":"2\u20133","key":"10.1016\/j.cger.2020.01.001_bib45","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1159\/000356531","article-title":"Depression and cognitive impairment in Parkinson's disease: a role for inflammation and immunomodulation?","volume":"21","author":"Pessoa Rocha","year":"2014","journal-title":"Neuroimmunomodulation"},{"issue":"6","key":"10.1016\/j.cger.2020.01.001_bib46","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1037\/neu0000353","article-title":"The relation of anxiety and cognition in Parkinson's disease","volume":"31","author":"Reynolds","year":"2017","journal-title":"Neuropsychology"},{"issue":"5","key":"10.1016\/j.cger.2020.01.001_bib47","first-page":"518","article-title":"Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment","volume":"14","author":"Pagonabarraga","year":"2015","journal-title":"LancetNeurol"},{"issue":"7","key":"10.1016\/j.cger.2020.01.001_bib48","first-page":"937","article-title":"Orthostatic hypotension and cognitive impairment in Parkinson's disease: causation or association?","volume":"31","author":"McDonald","year":"2016","journal-title":"MovDisord"},{"issue":"6","key":"10.1016\/j.cger.2020.01.001_bib49","first-page":"861","article-title":"Biomarkers for dementia and mild cognitive impairment in Parkinson's disease","volume":"31","author":"Delgado-Alvarado","year":"2016","journal-title":"MovDisord"},{"issue":"4","key":"10.1016\/j.cger.2020.01.001_bib50","first-page":"528","article-title":"Biomarkers for cognitive impairment in Lewy body disorders: status and relevance for clinical trials","volume":"33","author":"Siderowf","year":"2018","journal-title":"MovDisord"},{"issue":"4","key":"10.1016\/j.cger.2020.01.001_bib51","first-page":"503","article-title":"Evolution of diagnostic criteria and assessments for Parkinson's disease mild cognitive impairment","volume":"33","author":"Goldman","year":"2018","journal-title":"MovDisord"},{"issue":"2","key":"10.1016\/j.cger.2020.01.001_bib52","first-page":"183","article-title":"Progression of cognitive decline in Parkinson's disease","volume":"8","author":"Roheger","year":"2018","journal-title":"J\u00a0Parkinsons Dis"},{"issue":"11","key":"10.1016\/j.cger.2020.01.001_bib53","first-page":"1750","article-title":"Detectingmild cognitive deficits in Parkinson's disease: comparison of neuropsychological tests","volume":"33","author":"Hoogland","year":"2018","journal-title":"MovDisord"},{"issue":"3","key":"10.1016\/j.cger.2020.01.001_bib54","first-page":"499","article-title":"MoCA for cognitive screening in Parkinson's disease: beware of floor effect","volume":"33","author":"Federico","year":"2018","journal-title":"MovDisord"},{"issue":"3","key":"10.1016\/j.cger.2020.01.001_bib55","first-page":"402","article-title":"Diagnosing PD-MCI by MDS task force criteria: how many and which neuropsychological tests?","volume":"30","author":"Goldman","year":"2015","journal-title":"MovDisord"},{"key":"10.1016\/j.cger.2020.01.001_bib56","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/arclin\/acx090","article-title":"Some clinically useful information that neuropsychology provides patients, careparterns, neurologists, and neurosugeons about deep brain stimulation for Parkinson's disease","volume":"32","author":"Troster","year":"2017","journal-title":"Arch ClinNeuropsychol"},{"key":"10.1016\/j.cger.2020.01.001_bib57","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/arclin\/acx130","article-title":"The role of neuropsychologist on a movement disorders deep brain stimulation team","volume":"33","author":"Kubu","year":"2018","journal-title":"Arch ClinNeuropsychol"},{"key":"10.1016\/j.cger.2020.01.001_bib58","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev-med-010713-141500","article-title":"New frontiers in patient-reported outcomes: adverse event reporting, comparative effectiveness, and quality assessment","volume":"65","author":"Basch","year":"2014","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.cger.2020.01.001_bib59","series-title":"Clinical trials in neurology","article-title":"Clinical approaches to post-marketing drug safety assessment","author":"Dal Pan","year":"2012"},{"issue":"3","key":"10.1016\/j.cger.2020.01.001_bib60","first-page":"219","article-title":"Neuropsychological Predictors of patient-reported cognitive decline after deep brain stimulation in Parkinson's disease","volume":"41","author":"Mills","year":"2019","journal-title":"J\u00a0ClinExpNeuropsychol"},{"key":"10.1016\/j.cger.2020.01.001_bib61","first-page":"136","article-title":"Bilateral subthalamic nucleus stimulation in a parkinsonian patient wit preoperative deficits in speech and cognition: persistent improvement in mobility but increased dependency: a case study","volume":"15","author":"Hariz","year":"2000","journal-title":"MovDisord"},{"issue":"11","key":"10.1016\/j.cger.2020.01.001_bib62","first-page":"1471","article-title":"Advances in the treatment of cognitive impairment in Parkinson's disease","volume":"30","author":"Goldman","year":"2015","journal-title":"MovDisord"},{"issue":"2","key":"10.1016\/j.cger.2020.01.001_bib63","first-page":"180","article-title":"Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review","volume":"34","author":"Seppi","year":"2019","journal-title":"MovDisord"},{"issue":"2","key":"10.1016\/j.cger.2020.01.001_bib64","first-page":"169","article-title":"Bilateral deep brain stimulation of the nucleus basalis of Meynert for Parkinson disease dementia: a randomized clinical trial","volume":"75","author":"Gratwicke","year":"2018","journal-title":"JAMANeurol"},{"key":"10.1016\/j.cger.2020.01.001_bib65","first-page":"136","article-title":"The effects of exercise on cognition and gait in Parkinson's disease: a scoping review","volume":"95","author":"Intzandt","year":"2018","journal-title":"NeurosciBiobehav Rev"},{"issue":"2","key":"10.1016\/j.cger.2020.01.001_bib66","doi-asserted-by":"crossref","first-page":"e0193113","DOI":"10.1371\/journal.pone.0193113","article-title":"Effects of physical exercise programs on cognitive function in Parkinson's disease patients: a systematic review of randomized controlled trials of the last 10 years","volume":"13","author":"da Silva","year":"2018","journal-title":"PLoS One"},{"issue":"21","key":"10.1016\/j.cger.2020.01.001_bib67","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1212\/WNL.0000000000002145","article-title":"Cognitive training in Parkinson disease: a systematic review and meta-analysis","volume":"85","author":"Leung","year":"2015","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.cger.2020.01.001_bib68","first-page":"597","article-title":"Cognitive training and noninvasive brain stimulation for cognition in Parkinson's disease: a meta-analysis","volume":"31","author":"Lawrence","year":"2017","journal-title":"NeurorehabilNeuralRepair"},{"issue":"6","key":"10.1016\/j.cger.2020.01.001_bib69","first-page":"876","article-title":"Modifiable risk factors for cognitive impairment in Parkinson's disease: a systematic review and meta-analysis of prospective cohort studies","volume":"34","author":"Guo","year":"2019","journal-title":"MovDisord"},{"issue":"6","key":"10.1016\/j.cger.2020.01.001_bib70","first-page":"766","article-title":"Neuropsychological deficits associated with driving performance in Parkinson's and Alzheimer's disease","volume":"11","author":"Grace","year":"2005","journal-title":"J\u00a0IntNeuropsycholSoc"},{"issue":"6","key":"10.1016\/j.cger.2020.01.001_bib71","first-page":"629","article-title":"Neuropsychiatric symptoms and caregiver's burden in Parkinson's disease","volume":"21","author":"Martinez-Martin","year":"2015","journal-title":"ParkinsonismRelatDisord"},{"key":"10.1016\/j.cger.2020.01.001_bib72","first-page":"1362053","article-title":"Coping with cognitive impairment in people with Parkinson's disease and their carers: a qualitative study","volume":"2018","author":"Lawson","year":"2018","journal-title":"Parkinsons Dis"},{"key":"10.1016\/j.cger.2020.01.001_bib73","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/bs.irn.2017.05.014","article-title":"Palliative care and nonmotor symptoms in Parkinson's disease and parkinsonism","volume":"134","author":"Titova","year":"2017","journal-title":"Int Rev Neurobiol"},{"issue":"7","key":"10.1016\/j.cger.2020.01.001_bib74","first-page":"912","article-title":"Rivastigmine for mild cognitive impairment in Parkinson disease: a placebo-controlled study","volume":"30","author":"Mamikonyan","year":"2015","journal-title":"MovDisord"},{"issue":"5","key":"10.1016\/j.cger.2020.01.001_bib75","first-page":"709","article-title":"Rasagiline for mild cognitive impairment in Parkinson's disease: a placebo-controlled trial","volume":"31","author":"Weintraub","year":"2016","journal-title":"MovDisord"},{"issue":"3","key":"10.1016\/j.cger.2020.01.001_bib76","first-page":"416","article-title":"A\u00a0randomized clinical trial of atomoxetine for mild cognitive impairment in Parkinson's disease","volume":"4","author":"Hinson","year":"2017","journal-title":"MovDisordClinPract"}],"container-title":["Clinics in Geriatric Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074906902030001X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S074906902030001X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:55:33Z","timestamp":1760061333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S074906902030001X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":76,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S074906902030001X"],"URL":"https:\/\/doi.org\/10.1016\/j.cger.2020.01.001","relation":{},"ISSN":["0749-0690"],"issn-type":[{"value":"0749-0690","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cognitive Impairment and Dementia in Parkinson Disease","name":"articletitle","label":"Article Title"},{"value":"Clinics in Geriatric Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cger.2020.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}